Trial for the drug CT900 which targets ovarian cancer cells expanded into a larger trial

A trial for the drug CT900 (previously called ONX-0801) which targets ovarian cancer cells via a protein called the alpha-folate receptor is being expanded into a larger trial.

The drug could be suitable for women with ovarian cancer for whom chemotherapy has failed, and whose tumours have high levels of the alpha-folate receptor on the surface of cancer cells.

Read full article

Comments (0)

Comment (maximum 3500 characters) *

Add a picture

Notify me when someone makes a comment

First name *

Last name *

Email *

Which country do you live in?

Please enter your postcode*

Address line 1

Address line 2

Town or city

Keeping In Touch

We'd love to keep you posted with our news, activities and how you can help in other ways. We'll never sell or swap your details with anybody else. You are free to change your mind at anytime. Please indicate how you would like to hear from us by using the tick boxes below

Via email

Via telephone

Via SMS

Via post

Which country do you live in?

Please enter your postcode*

Address line 1

Address line 2

Town or city

Your Privacy

We will always store your personal details securely. We'll use them to provide the service that you have requested, and communicate with you in the way(s) that you have agreed to. Your data may also be used for analysis purposes, to help us provide the best service possible. For full details see our Privacy Policy

By submitting this form you are agreeing to our terms and conditions

Latest

Help Kath to make a real difference

I am walking down the catwalk on March 28th at the Touch of Teal Tea in London.
I'm raising money for Ovacome, who provide support and information to those affected by ovarian cancer. This cause means a lot to me, and I hope that you'll consider contributing towards their work.
MRI tool that can diagnose difficult cases of ovarian cancer to be tested at 18 UK trusts

The new tool can identify cases of ovarian cancer which are difficult to diagnose using standard methods.
Help Paul to make a real difference

I'm raising money for Ovacome, who provide support and information to those affected by ovarian cancer.
I will be running both the London (April) and Edinburgh (May) marathons one month apart, in memory of 2 close family members taken too soon by this disease, and in hope that it doesnt impact anymore of our family.

My employer, Aviva, will match £ for £ up to £250. Any small amount you are able to contribute will be very much appreciated
Send Jane down the Catwalk!

I'm raising money for Ovacome, who provide support and information to all of us affected by ovarian cancer. This cause means a lot to me, and I hope that you'll consider contributing towards their work.